304 related articles for article (PubMed ID: 30916582)
1. To test, or not to test: that is the question for the future of lipoprotein(a).
Ellis KL; Chakraborty A; Moses EK; Watts GF
Expert Rev Cardiovasc Ther; 2019 Apr; 17(4):241-250. PubMed ID: 30916582
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives.
Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM
Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) and mortality-a high risk relationship.
Klingel R; Heibges A; Fassbender C
Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):13-19. PubMed ID: 30838554
[TBL] [Abstract][Full Text] [Related]
4. Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a).
Wilson DP; Koschinsky ML; Moriarty PM
Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):159-173. PubMed ID: 33534258
[TBL] [Abstract][Full Text] [Related]
5. Lp(a): Addressing a Target for Cardiovascular Disease Prevention.
Vasquez N; Joshi PH
Curr Cardiol Rep; 2019 Jul; 21(9):102. PubMed ID: 31367887
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis.
Klingel R; Heigl F; Schettler V; Roeseler E; Grützmacher P; Hohenstein B; Vogt A; Fassbender C; Heibges A; Julius U
Atheroscler Suppl; 2019 Dec; 40():17-22. PubMed ID: 31818445
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies.
Cesaro A; Schiavo A; Moscarella E; Coletta S; Conte M; Gragnano F; Fimiani F; Monda E; Caiazza M; Limongelli G; D'Erasmo L; Riccio C; Arca M; Calabrò P
J Cardiovasc Med (Hagerstown); 2021 Mar; 22(3):151-161. PubMed ID: 32858625
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) and Increased Cardiovascular Risk in Women.
Costello BT; Silverman ER; Doukky R; Braun LT; Aggarwal NT; Deng Y; Li Y; Lundberg G; Williams KA; Volgman AS
Clin Cardiol; 2016 Feb; 39(2):96-102. PubMed ID: 26880352
[TBL] [Abstract][Full Text] [Related]
9. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
[TBL] [Abstract][Full Text] [Related]
10. Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation.
Reyes-Soffer G; Westerterp M
Pharmacol Res; 2021 Jul; 169():105689. PubMed ID: 34033878
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a): Its relevance to the pediatric population.
McNeal CJ
J Clin Lipidol; 2015; 9(5 Suppl):S57-66. PubMed ID: 26343213
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a): cardiovascular risk and emerging therapies.
Fujino M; Nicholls SJ
Expert Rev Cardiovasc Ther; 2023 Apr; 21(4):259-268. PubMed ID: 37010028
[TBL] [Abstract][Full Text] [Related]
13. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes.
Ma GS; Chiou TT; Wilkinson MJ
Curr Cardiol Rep; 2023 Oct; 25(10):1175-1187. PubMed ID: 37632608
[TBL] [Abstract][Full Text] [Related]
14. Current and future role of lipoprotein(a) in preventive cardiology.
Berman AN; Blankstein R
Curr Opin Cardiol; 2019 Sep; 34(5):514-518. PubMed ID: 31261178
[TBL] [Abstract][Full Text] [Related]
15. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.
Koschinsky ML; Bajaj A; Boffa MB; Dixon DL; Ferdinand KC; Gidding SS; Gill EA; Jacobson TA; Michos ED; Safarova MS; Soffer DE; Taub PR; Wilkinson MJ; Wilson DP; Ballantyne CM
J Clin Lipidol; 2024; 18(3):e308-e319. PubMed ID: 38565461
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention.
Weiss MC; Berger JS; Gianos E; Fisher E; Schwartzbard A; Underberg J; Weintraub H
J Clin Lipidol; 2017; 11(5):1177-1180. PubMed ID: 28801030
[TBL] [Abstract][Full Text] [Related]
17. Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees.
Kronenberg F; Mora S; Stroes ESG
Curr Opin Lipidol; 2022 Dec; 33(6):342-352. PubMed ID: 36251423
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) Testing Patterns in a Large Health System.
Kelsey M; Page C; Alhanti B; Rhodes SL; Kent ST; Peterson E; Pagidipati N
Am J Cardiol; 2021 Aug; 153():43-50. PubMed ID: 34210501
[TBL] [Abstract][Full Text] [Related]
19. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.
Tsimikas S
J Am Coll Cardiol; 2017 Feb; 69(6):692-711. PubMed ID: 28183512
[TBL] [Abstract][Full Text] [Related]
20. Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?
Loh WJ; Watts GF
Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):94-102. PubMed ID: 36468313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
